Sanofi has moved to bolster its vaccines business by reaching a deal to buy London, UK-based biotech Vicebio, which was formed to produce improved, more potent shots that are simpler to manufacture.

Oracle faces a class action lawsuit from bondholders claiming the company misled investors. Wall Street analysts slashed price targets across the board over AI spending. Microsoft's earnings didn't ...

Nuclear energy has come back into favor because it's a carbon-free source of energy. Stocks like Cameco, GE Vernova, and Brookfield Renewable offer exposure to nuclear energy. Understand the risks and ...